Innovation and Biomarkers in Cancer Drug Development (IBCD) A Joint Meeting by EORTC, NCI and EMA, AACR
In-Person EventNov 29 - 30, 2018Brussels, Brussel, BE
OVERVIEW
Innovation and Biomarkers in Cancer Drug Development (IBCD) A Joint Meeting by European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and European Medicines Agency (EMA), American Association for Cancer Research (AACR) is organized by European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and European Medicines Agency (EMA), American Association for Cancer Research (AACR) and will be held during Nov 29 - 30, 2018 at Brussels, Belgium.
Additional details will be posted as soon as they are available.